Results 151 to 160 of about 50,518 (225)

Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients. [PDF]

Clin Exp Med, 2023
Hanafy AS, Seleem WM, Elkattawy HA.
europepmc   +1 more source

Vaccination Patterns and Determinants of Influenza and Pneumococcal Vaccines Among COPD Patients in Shanghai, China: A Comparative Analysis of Differing Funding Strategies. [PDF]

Vaccines (Basel)
Tang X, Wang S, Xu H, Tang H, Bian F, Wan K, Gong R, Lin W, Ye J, Wu Q, Zhang Q.   +10 more
europepmc   +1 more source

Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. [PDF]

Lancet HIV, 2021
Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, Zimmer B, Bone F, Newton L, Fenton T, Kiely J, Johnson MJ, Joao EC, Santos BR, Machado ES, Pinto JA, Chakhtoura N, Duarte G, Mussi-Pinhata MM, NICHD P1091 study team.   +19 more
europepmc   +1 more source

Do Family Physicians' Recommendations for Influenza and Pneumococcal Vaccines Impact the Elderly Aged ≥60 Years? A Cross-Sectional Study in Six Chinese Cities. [PDF]

Vaccines (Basel)
Wang Y, Dai J, Yuan S, Chen Y, Zhang Z, Zhu L, Liu G, Zeng Q, Qiu Q, Luo C, Deng R, You L.   +11 more
europepmc   +1 more source

Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database. [PDF]

Front Cell Infect Microbiol
Zheng X, Liu M, Ding A, Zhang S, Wu L, Kong F, Sun W, Peng Y, Xi Y.   +8 more
europepmc   +1 more source

Inflammatory Knee Reaction Mimicking Septic Arthritis Following Closely Spaced Pneumococcal Vaccines in a Pediatric Patient Undergoing Immunodeficiency Evaluation. [PDF]

Cureus
Soule SM, Huntsman A, Chandra S, Thorne T, Holmes S, McKinley K.   +5 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Pneumococcal Vaccines in the Pediatric Population: A Systematic Review. [PDF]

Healthcare (Basel)
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc   +1 more source

Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older Adults. [PDF]

Am J Prev Med
Smith KJ, Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK.   +6 more
europepmc   +1 more source

Designing ecologically optimized pneumococcal vaccines using population genomics. [PDF]

Nat Microbiol, 2020
Colijn C, Corander J, Croucher NJ.
europepmc   +1 more source

Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. <i>Vaccines</i> 2025, <i>13</i>, 192. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source